Linda Chang (Linda Santiago)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 2

Top Topics

Binding Protein

Ejection Fraction

Rheumatoid Arthritis Patients

Top Venues

Molecular cancer therapeutics

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Mary Ellen Molloy, Wade H Aaron, Manasi Barath, Mabel C Bush, Evan C Callihan, Kevin Carlin, Michael Cremin, Thomas Evans, Maria Gamez Guerrero, Golzar Hemmati, Avneel S Hundal, Llewelyn Lao, Payton Laurie, Bryan D Lemon, S Jack Lin, Jessica O'Rear, Purbasa Patnaik, Sony Sotelo Rocha, Linda Chang, Kathryn L Strobel, Laura B Valenzuela, Chi-Heng Wu, Stephen Yu, Timothy Z Yu, Banmeet S Anand, Che-Leung Law, Liping L Sun, Holger Wesche, Richard J Austin
HPN328, a Trispecific T Cell-activating Protein Construct Targeting DLL3-Expressing Solid Tumors. Molecular cancer therapeutics (2024)
Julie Douthwaite, Jacques Moisan, Cyril Privezentzev, Blagoje Soskic, Shereen Sabbah, E Suzanne Cohen, Andie Collinson, Elizabeth England, Catherine Chaillan Huntington, Ben Kemp, Li Zhuang, Suzanne Hudak, D Gareth Rees, Debbie Goldberg, Chris Barton, Linda Chang, Inna Vainshtein, Meina Liang, Laurie Iciek, Philip Ambery, Mark Peakman, Tristan J Vaughan, Timothy I M Tree, David Michael Sansom, Michael A Bowen, Ralph R Minter, Lutz Jermutus
A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding. Journal of immunology (Baltimore, Md. : 1950) 198 (1) (2016)